Lv4
620 积分 2023-12-30 加入
Time trends and regional variation in utilization of antidiabetic medicines in China, 2015–2022
1个月前
已完结
Changes in insulin utilization in China from 2020 to 2022
1个月前
已完结
Disparity in Guideline‐Based Antidiabetic Drugs Prescribing for Type 2 Diabetes Patients in Primary Healthcare Facilities Across China, 2017–2019
1个月前
已完结
Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
3个月前
已完结
Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections
3个月前
已完结
Lowest Glucose Variability and Hypoglycemia Are Observed With the Combination of a GLP-1 Receptor Agonist and Basal Insulin (VARIATION Study)
3个月前
已完结
Time to redefine success in continuous glucose monitoring
3个月前
已完结
Evaluation of cardiovascular risk according to the 2019 ESC/EASD guidelines in type 1 diabetes mellitus patients: A population-based survey study
6个月前
已完结
Data-driven subgroups of newly diagnosed type 2 diabetes and the relationship with cardiovascular diseases at genetic and clinical levels in Chinese adults
6个月前
已完结
Development of a predictive model for gastrointestinal side effects of metformin treatment in Chinese individuals with type 2 diabetes based on four randomised clinical trials
6个月前
已完结
皖公网安备34019202002308
